Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
36,825
Sort by:
2017-2021 Italy HIV/AIDS Diagnostics Market Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 810.00
... sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, DiaSorin, Grifols, Ortho Clinical Diagnostics/J&J, Roche ...
February 2017
60 pages
2017-2021 Japan HIV/AIDS Diagnostics Market Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 810.00
... forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: ... provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Fujirebio, Grifols, Ortho Clinical Diagnostics/J&J, Roche, ...
February 2017
60 pages
2017-2021 Spain HIV/AIDS Diagnostics Market Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 810.00
... sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: ... and market share estimates for major suppliers of AIDS tests, including Abbott, Biokit, bioMerieux, Bio-Rad, Fujirebio, Grifols, Ortho-Clinical Diagnostics/J&J, ...
February 2017
60 pages
2017-2021 UK HIV/AIDS Diagnostics Market Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 810.00
... sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics/J&J, Roche, and ...
February 2017
60 pages
2017-2021 US HIV/AIDS Diagnostics Market Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 810.00
... sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: Hospitals ... sales and market Share estimates for major suppliers of AIDS testing including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics, and Roche ...
February 2017
60 pages
